ArticleAnnals of translational medicine2022

Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2-), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health.

Ana-Alicia Beltran-Bless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.